Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer. - Shahin MS; Lorusso D; Backes FJ; Barretina-Ginesta MP; O'Malley DM; Forget F; Pothuri B; Hietanen S; McCormick CC; Abadie-Lacourtoisie S; O'Cearbhaill RE; Heitz F; et al. (Gynecologic oncology, 2026)